Ansell Limited (PD1A) - Total Liabilities

Latest as of June 2025: €1.34 Billion EUR ≈ $1.57 Billion USD

Based on the latest financial reports, Ansell Limited (PD1A) has total liabilities worth €1.34 Billion EUR (≈ $1.57 Billion USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Ansell Limited - Total Liabilities Trend (2004–2025)

This chart illustrates how Ansell Limited's total liabilities have evolved over time, based on quarterly financial data. See PD1A net working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Ansell Limited Competitors by Total Liabilities

The table below lists competitors of Ansell Limited ranked by their total liabilities.

Company Country Total Liabilities
Almirall S.A.
MC:ALM
Spain €882.40 Million
Atlanta Braves Holdings, Inc. Series C Common Stock
NASDAQ:BATRK
USA $7.49 Billion
Tarsus Pharmaceuticals Inc
NASDAQ:TARS
USA $232.18 Million
Shandong Humon Smelting Co Ltd
SHE:002237
China CN¥25.69 Billion
CES Energy Solutions Corp
TO:CEU
Canada CA$850.54 Million
CLARIANT ADR 1/SF 4
F:CLRS
Germany €3.69 Billion
Momentum Metropolitan Holdings Ltd
JSE:MTM
South Africa ZAC848.83 Billion
TP ICAP GROUP PLC LS -25
F:8D7
Germany €6.14 Billion

Liability Composition Analysis (2004–2025)

This chart breaks down Ansell Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Ansell Limited market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.13 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.68 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.40 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Ansell Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Ansell Limited (2004–2025)

The table below shows the annual total liabilities of Ansell Limited from 2004 to 2025.

Year Total Liabilities Change
2025-06-30 €1.34 Billion
≈ $1.57 Billion
+0.55%
2024-06-30 €1.33 Billion
≈ $1.56 Billion
+45.59%
2023-06-30 €915.20 Million
≈ $1.07 Billion
-3.62%
2022-06-30 €949.60 Million
≈ $1.11 Billion
-19.05%
2021-06-30 €1.17 Billion
≈ $1.37 Billion
-22.97%
2020-06-30 €1.52 Billion
≈ $1.78 Billion
+10.51%
2019-06-30 €1.38 Billion
≈ $1.61 Billion
+4.76%
2018-06-30 €1.32 Billion
≈ $1.54 Billion
-17.18%
2017-06-30 €1.59 Billion
≈ $1.86 Billion
+2.22%
2016-06-30 €1.55 Billion
≈ $1.82 Billion
+28.44%
2015-06-30 €1.21 Billion
≈ $1.41 Billion
-0.79%
2014-06-30 €1.22 Billion
≈ $1.43 Billion
+145.33%
2006-06-30 €497.05 Million
≈ $581.11 Million
+7.73%
2005-06-30 €461.39 Million
≈ $539.41 Million
-4.21%
2004-06-30 €481.69 Million
≈ $563.15 Million
--

About Ansell Limited

F:PD1A Germany Medical Instruments & Supplies
Market Cap
$2.63 Billion
€2.25 Billion EUR
Market Cap Rank
#5352 Global
#851 in Germany
Share Price
€15.60
Change (1 day)
-0.64%
52-Week Range
€15.50 - €21.00
All Time High
€23.56
About

Ansell Limited designs, sources, develops, manufactures, distributes, and sells hand and body protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. It operates through two segments: Healthcare and Industrial. The Healthcare segment manufactures and markets solutions, including surgical gloves, single-use and examination gloves,… Read more